Genome-wide association study reveals shared and distinct genetic architecture underlying fatty acid and bioactive oxylipin metabolites in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Carolina G Downie,Heather Highland,Mona Alotaibi,Barrett M Welch,Annie Green Howard,Susan Cheng,Nick Miller,Mohit Jain,Robert C. Kaplan,Adam G Lilly,Tao Long,Tamar Sofer,Bharat Thyagarajan,Bing Yu,Kari E. North,Christy L. Avery
DOI: https://doi.org/10.1101/2024.05.21.24307719
2024-05-23
Abstract:Bioactive fatty acid-derived oxylipin molecules play key roles in mediating inflammation and oxidative stress, which underlie many chronic diseases. Circulating levels of fatty acids and oxylipins are influenced by both environmental and genetic factors; characterizing the genetic architecture of bioactive lipids could yield new insights into underlying biological pathways. Thus, we performed a genome wide association study (GWAS) of n=81 fatty acids and oxylipins in n=11,584 Hispanic Community Health Study/Study of Latinos (HCHS/SOL) participants with genetic and lipidomic data measured at study baseline (58.6% female, mean age = 46.1 years, standard deviation = 13.8 years). Additionally, given the effects of central obesity on inflammation, we examined interactions with waist circumference using two-degree-of-freedom joint tests. Heritability estimates ranged from 0% to 47.9%, and 48 of the 81oxylipins and fatty acids were significantly heritable. Moreover, 40 (49.4%) of the 81 oxylipins and fatty acids had at least one genome-wide significant (p< 6.94E-11) variant resulting in 19 independent genetic loci involved in fatty acid and oxylipin synthesis, as well as downstream pathways. Four loci (lead variant minor allele frequency [MAF] range: 0.08-0.50), including the desaturase-encoding FADS and the OATP1B1 transporter protein-encoding SLCO1B1, exhibited associations with four or more fatty acids and oxylipins. The majority of the 15 remaining loci (87.5%) (lead variant MAF range = 0.03-0.45, mean = 0.23) were only associated with one oxylipin or fatty acid, demonstrating evidence of distinct genetic effects. Finally, while most loci identified in two-degree-of-freedom tests were previously identified in our main effects analyses, we also identified an additional rare variant (MAF = 0.002) near CARS2, a locus previously implicated in inflammation. Our analyses revealed shared and distinct genetic architecture underlying fatty acids and oxylipins, providing insights into genetic factors and motivating future multi-omics work to characterize these compounds and elucidate their roles in disease pathways.
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to reveal the genetic structure of fatty acids and bioactive oxylipin metabolites in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) through genome - wide association studies (GWAS). Specifically, the study aims to: 1. **Evaluate the influence of genetic factors on the levels of fatty acids and oxylipin metabolites**: By estimating the heritability of these metabolites, understand the extent to which they are influenced by genetic factors. 2. **Identify genetic loci significantly associated with fatty acids and oxylipin metabolites**: Through GWAS analysis of 81 fatty acids and oxylipin metabolites, find gene variants significantly associated with these metabolites. 3. **Explore the influence of central obesity (such as waist circumference) on fatty acids and oxylipin metabolites**: By introducing waist circumference as an interaction term, assess whether central obesity will affect the genetic effects of these metabolites. 4. **Reveal the shared and specific genetic structures of fatty acids and oxylipin metabolites**: Analyze the genetic correlations between different metabolites to determine whether there are common genetic regulatory mechanisms or specific genetic effects. ### Main research content - **Sample selection**: The study is based on 11,584 participants in the HCHS/SOL who have genotype and lipidomics data. - **Data analysis methods**: - **Heritability estimation**: Use Haseman - Elston regression to estimate SNP - based heritability. - **Main - effect GWAS**: Conduct GWAS analysis on 81 fatty acids and oxylipin metabolites to identify significantly associated genetic loci. - **Joint - effect GWAS**: Introduce waist circumference as an interaction term and conduct a two - degree - of - freedom joint test to increase the ability to identify genetic loci with main effects and interaction effects. ### Research findings - **Heritability**: 48 metabolites showed significant heritability, ranging from 0% to 47.9%. - **Significant genetic loci**: At least one genome - wide significant genetic variant was found in 40 metabolites, involving 19 independent genetic loci. - **Shared and specific genetic structures**: Four pleiotropic loci (SLCO1B1, FADS, PKD2L1, and PPP1R3B) associated with multiple metabolites were found, as well as 15 specific loci associated with only a few metabolites. - **New findings**: Five related genetic loci were found in a "potential new oxylipin", one of which is CARS2 that has not been reported before. ### Conclusion This study reveals the shared and specific genetic structures of fatty acids and oxylipin metabolites, provides new insights into understanding the roles of these metabolites in inflammation and chronic diseases, and lays the foundation for further multi - omics research.